Price:
Rs. 5,300.00
Sample Type: PURE CULTURE
Fasting Not Requierd
Booking Procedure:
- Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
- Soft copy reports will be sent to your email address within 24 to 48 hours.
Frequently Asked Questions (FAQ's):
What does the AFB 1st Line Drug Susceptibility Panel test include?
This Metropolis Healthcare test evaluates Mycobacterium tuberculosis against four key first-line anti-TB drugs—Streptomycin, Isoniazid, Rifampicin, and Ethambutol—to determine drug sensitivity or resistance.
Why choose Metropolis Healthcare for this TB drug sensitivity test?
Metropolis Healthcare provides advanced TB diagnostics, skilled microbiologists, high-precision testing systems, and standardized drug-susceptibility protocols for accurate and dependable results.
What sample type is required for this test at Metropolis Healthcare?
A pure culture of Mycobacterium tuberculosis is required so Metropolis Healthcare can perform reliable and detailed drug resistance analysis.
Who should undergo this test at Metropolis Healthcare?
Patients newly diagnosed with TB, those suspected of drug-resistant tuberculosis, or individuals not responding well to standard treatment may benefit from this first-line susceptibility evaluation.
How does Metropolis Healthcare perform the testing?
The pure culture is exposed to each of the four first-line drugs under controlled laboratory conditions. Metropolis Healthcare follows rigorous quality standards to ensure accurate interpretation of sensitivity and resistance.
How long does it take to receive the results?
Results typically take several days, as Metropolis Healthcare conducts careful incubation and analysis to ensure precise susceptibility reporting.
How does this test help in TB treatment?
It helps identify resistance to essential first-line drugs, enabling doctors to select the correct treatment regimen and avoid ineffective medications.
Is this test useful for monitoring ongoing TB therapy?
Yes. It supports treatment adjustments when drug resistance is suspected, helping clinicians manage TB more effectively with the guidance of Metropolis Healthcare’s accurate results.